Martin Leon

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada.

Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada.

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada.

Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.

Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia.

Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

Cardiomech AS develops the next generation of interventional devices for structural heart disease. It provides transfemoral transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve. The company was founded by Nikolai Hiorth and Jacob Bergsland and is headquartered in Trondheim, Norway.

Toys "R" Us Ltd. retails toys and baby products. The company is headquartered in Concord, Canada.

Spinal Stabilization Technologies LLC designs, develops, and manufactures spinal medical devices that meet or exceed the expectations of our patients, customers, and regulatory agencies; and to maintain and improve the effectiveness of our quality management system. The company was founded in 2010 and is headquartered in San Antonio, TX.

Croivalve Ltd. develops medical device for treatment of tricuspid regurgitation. The company was founded by Lucy O'Keeffe and Martin Quinn in 2016 and is headquartered in Dublin, Ireland.

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA.

415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Moray Medical is a company that aims to revolutionize catheter technology by offering physicians a robotic catheter-based approach to an otherwise challenging and traumatic operation. The company is based in Mountain View, CA. Moray Medical's robotic system provides physicians with the dexterity and precision needed to treat hundreds of thousands of patients who are too frail to survive the trauma of conventional surgery. The company was founded by Keith Phillip Laby and Mark Barrish, with Mark Barrish serving as the CEO since incorporation.

The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012.

Vessl, Inc. engages in manufacturing soft drinks. It offers peach ginger black tea, pomegranate acai white tea, unsweetened black tea, citrus mint green tea, and recovery formula. The company was founded by Walter Apodaca and Don Park on February 10, 2014 and is headquartered in Tempe, AZ.

Protembis GmbH develops and manufactures medical devices for surgical heart procedures. Its device ProtEmbo is intended to protect patients from the risk of suffering a stroke during these procedures. The company was founded by Karl von Mangoldt and Conrad Rasmus in 2013 and is headquartered in Hamburg, Germany.

Iaculor Injection, Inc. develops needle free medical devices. It engages in the development and commercialization of needle-free medical devices for injecting drugs and vaccines. The company was founded by Martin Brouillette and is headquartered in Sherbrooke, Canada.